Brief: Contineum Therapeutics Initiates Patient Dosing In Phase 1B Positron Emission Tomography (Pet) Trial Of Pipe-791

Contineum Therapeutics

16/12/2024 21:21

Dec 16 (Reuters) - Contineum Therapeutics Inc  CTNM.O :
    * CONTINEUM THERAPEUTICS INITIATES PATIENT DOSING IN PHASE
1B
POSITRON EMISSION TOMOGRAPHY (PET) TRIAL OF PIPE-791
    * CONTINEUM THERAPEUTICS INC - TOPLINE DATA READOUT EXPECTED
IN Q2
2025
    * CONTINEUM THERAPEUTICS INC - DOSES FIRST COHORT IN
PIPE-791
PHASE 1B TRIAL
    * CONTINEUM THERAPEUTICS INC - ANTICIPATES TOPLINE DATA FROM
PIPE-791 TRIAL IN Q2 2025

Source text:  ID:nBwbSfwCza 
Further company coverage:  CTNM.O 

 ((Reuters.Briefs@thomsonreuters.com;))